Skip to content

Comparison of the onset time of chloroprocaine and lidocaine combined with sufentanil for epidural block for cesarean section

Comparison of the onset time of chloroprocaine and lidocaine combined with sufentanil for epidural block for cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018986
Enrollment
Unknown
Registered
2018-10-20
Start date
2018-10-20
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

Group 1:Chlorprocaine administered into the epidural space
Group 2:Sufentanil+Lidocaine administered into the epidural space

Sponsors

Obstetrics and Gynecology Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy single parturients, aged 18-45 years, ASA Class I-II, between 38 and 42 wk gestation,undergoing elective Caesarean section under epidural anaesthesia,can communicate well and sign informed consent were eligible for the study.

Exclusion criteria

Exclusion criteria: Patients with contraindications to epidural block(patient refusal, unstable haemodynamics, coagulation abnormality), history of hypersensitivity to any study drugs, body mass index >40 kg/m2, hypertensive disorders of pregnancy,Pre-eclampsia, placenta previa and fetal distress, patients with heart, liver and kidney disease, previous history of mental illness, history of previous neuromuscular disease, epidural anesthesia failure were excluded.

Design outcomes

Primary

MeasureTime frame
onset time;

Secondary

MeasureTime frame
Visual analogue pain score;Satisfaction score;

Countries

China

Contacts

Public ContactShaoqiang Huang

Obstetrics and Gynecology Hospital, Fudan University

llknight115@163.com+86 18121299307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026